These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26482099)

  • 1. Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments.
    Stornaiuolo M; Bruno A; Botta L; La Regina G; Cosconati S; Silvestri R; Marinelli L; Novellino E
    Sci Rep; 2015 Oct; 5():15453. PubMed ID: 26482099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
    Ahn KH; Mahmoud MM; Kendall DA
    J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
    Shore DM; Baillie GL; Hurst DH; Navas F; Seltzman HH; Marcu JP; Abood ME; Ross RA; Reggio PH
    J Biol Chem; 2014 Feb; 289(9):5828-45. PubMed ID: 24366865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor.
    Iliff HA; Lynch DL; Kotsikorou E; Reggio PH
    J Comput Chem; 2011 Jul; 32(10):2119-26. PubMed ID: 21523790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
    Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
    Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators restore orthosteric agonist binding to mutated CB
    Dopart R; Kendall DA
    J Pharm Pharmacol; 2020 Jan; 72(1):84-91. PubMed ID: 31722122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
    Dopart R; Lu D; Lichtman AH; Kendall DA
    Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569.
    Aderibigbe AO; Pandey P; Doerksen RJ
    J Biomol Struct Dyn; 2022 Aug; 40(13):5729-5747. PubMed ID: 33480332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor.
    Shao Z; Yan W; Chapman K; Ramesh K; Ferrell AJ; Yin J; Wang X; Xu Q; Rosenbaum DM
    Nat Chem Biol; 2019 Dec; 15(12):1199-1205. PubMed ID: 31659318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
    Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
    Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of chemical functionalities of indole-2-carboxamides to improve allosteric parameters for the cannabinoid receptor 1 (CB1).
    Khurana L; Ali HI; Olszewska T; Ahn KH; Damaraju A; Kendall DA; Lu D
    J Med Chem; 2014 Apr; 57(7):3040-52. PubMed ID: 24635495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1).
    Mahmoud MM; Ali HI; Ahn KH; Damaraju A; Samala S; Pulipati VK; Kolluru S; Kendall DA; Lu D
    J Med Chem; 2013 Oct; 56(20):7965-75. PubMed ID: 24053617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).
    Ahn KH; Mahmoud MM; Shim JY; Kendall DA
    J Biol Chem; 2013 Apr; 288(14):9790-9800. PubMed ID: 23449980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assay.
    Bruno A; Lembo F; Novellino E; Stornaiuolo M; Marinelli L
    Sci Rep; 2014 Jan; 4():3757. PubMed ID: 24441508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery.
    Gado F; Meini S; Bertini S; Digiacomo M; Macchia M; Manera C
    Future Med Chem; 2019 Aug; 11(15):2019-2037. PubMed ID: 31517528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.
    Obi P; Natesan S
    J Med Chem; 2022 Sep; 65(18):12240-12255. PubMed ID: 36066412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical model.
    Green HM; Yang L; Zhu X; Finlay DB; Duffull SB; Glass M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5105-5118. PubMed ID: 38227196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB
    Yang L; Zhu X; Finlay DB; Green H; Glass M; Duffull SB
    Br J Pharmacol; 2023 Oct; 180(20):2661-2676. PubMed ID: 37277184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.